🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplat...
Status
Terminated
Location
Quest Clinical Research
Start Date
2019-04-22
Trial ID
NCT03838367
PRO 140 2103 is a multicenter, randomized parallel group study, conducted i...
Status
Withdrawn
Location
Stanford University (Stanford AIDS Clinical Trials Unit)
Start Date
2014-09
Trial ID
NCT02257788
Treatments Being Tested
PRO 140\_CD02 Extension study seeks to evaluate the long-term efficacy, saf...
Status
Terminated
Location
Multiple Locations
Start Date
2016-11-03
Trial ID
NCT02990858
Treatments Being Tested
This is aPhase II Study of Leronlimab (PRO 140) in combination with Regoraf...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-09-20
Trial ID
NCT05730673
This is an open label, randomized, two arm, multi-center study to explore t...
Status
Active Not Recruiting
Location
City of Hope Orange County Lennar Foundation Cancer Center
Start Date
2025-06-16
Trial ID
NCT06699836
Treatments Being Tested
The primary objectives of the trial are to assess the efficacy, clinical sa...
Status
Completed
Location
CD02_OpenLabel Investigational Site
Start Date
2018-06-25
Trial ID
NCT03902522
Treatments Being Tested
This study is a Phase 2b/3, multi-center study designed to evaluate the eff...
Status
Completed
Location
CD03 Investigational site
Start Date
2016-12-07
Trial ID
NCT02859961
Treatments Being Tested
This study is a Phase 2b/3 multi-center extension study designed to evaluat...
Status
Terminated
Location
Quest Clinical Research
Start Date
2017-08-29
Trial ID
NCT05271370
Treatments Being Tested
This is a phase II study of of Leronlimab (PRO 140)-Humanized monoclonal an...
Status
Completed
Location
Southern California Research Center
Start Date
2020-12-01
Trial ID
NCT04521114
Treatments Being Tested